<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34262566</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Case Report: Systemic Sclerosis After Covid-19 Infection.</ArticleTitle><Pagination><StartPage>686699</StartPage><MedlinePgn>686699</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">686699</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2021.686699</ELocationID><Abstract><AbstractText>The coronavirus disease (COVID-19) is a respiratory tract infection caused by the new virus SARS-CoV-2. The acute phase of the infection may in certain individuals be followed by another longer phase of disease (long COVID) of unknown etiology probably associated in certain cases with autoimmune activation. It has been shown that COVID-19 can trigger autoantibody production and in genetically predisposed patients may cause the onset or exacerbation of autoimmune diseases. We are reporting a case of mild COVID-19 infection complicated by autoantibody production and cutaneous and gastrointestinal symptoms and subsequently diagnosed with systemic sclerosis (SSc). A 47-year-old man with no history of any autoimmune diseases and in good health became sick together with his family on the 12th of November with mild symptoms: tiredness, fever, cough, and sore throat. Oropharyngeal swab for SARS-CoV-2 tested positive. He was isolated at home and did not require hospitalization. Three weeks later he presented with clinical manifestation compatible with suspicion of SSc. He briefly presented with skin rush, periorbital edema and conjunctivitis, vomiting, dysphagia, burning sensation in the skin, above all in the fingertips and around the mouth, puffy fingers, Raynaud's phenomenon, pain at the fingertip of the middle finger where a depressed area was noticed without a clear ulceration. ANA showed a strongly positive nucleolar pattern. Anti-PM/Scl 75 and PM/Scl 100 resulted positive. High-resolution computed tomography (HCRT) showed early stage of interstitial lung disease (ILD). The patient was diagnosed with SSc based on the persistence of autoantibodies and the clinical and radiological pictures according to the ACR/EULAR classification (scores: puffy finger, 2; ILD, 2; Raynaud's phenomenon, 3; SSc related antibodies, 3; total 10). There are several cases described in the medical literature of possible new onset of SLE after COVID-19 infection. This is the first case that describes a possible new onset of SSc. Conclusion: SARS-CoV-2 may trigger systemic sclerosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Fineschi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fineschi</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Public Health and Caring Sciences, Unit of General Practice, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>&#xd6;sthammar Health Care Centre, &#xd6;sthammar, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002121">Calcium Channel Blockers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054328">Proton Pump Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="Y">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002121" MajorTopicYN="N">Calcium Channel Blockers</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017563" MajorTopicYN="N">Lung Diseases, Interstitial</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054328" MajorTopicYN="N">Proton Pump Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011928" MajorTopicYN="N">Raynaud Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012595" MajorTopicYN="N">Scleroderma, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">scleroderma</Keyword><Keyword MajorTopicYN="N">systemic sclerosis</Keyword></KeywordList><CoiStatement>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34262566</ArticleId><ArticleId IdType="pmc">PMC8273695</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.686699</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hughes M, Herrick AL. Systemic Sclerosis. Br J Hops Med (2019) 80(9):530&#x2013;6. 10.12968/hmed.2019.80.9.530</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/hmed.2019.80.9.530</ArticleId><ArticleId IdType="pubmed">31498665</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. . 2013&#xa0;Classification&#xa0;Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Ann Rheum Dis (2013) 72(11):1747&#x2013;55. 10.1136/annrheumdis-2013-204424</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-204424</ArticleId><ArticleId IdType="pubmed">24092682</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanke K, Br&#xfc;ckner CS, D&#xe4;hnrich C, Huscher D, Komorowski L, Meyer W, et al. . Antibodies Against&#xa0;PM/Scl-75&#xa0;and&#xa0;PM/Scl-100&#xa0;Are Independent Markers for Different Subsets of Systemic Sclerosis Patients. Arthritis Res Ther (2009) 11(1):R22. 10.1186/ar2614</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2614</ArticleId><ArticleId IdType="pmc">PMC2688254</ArticleId><ArticleId IdType="pubmed">19220911</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M Assassi S. The Role of Type 1 Interferon in Systemic Sclerosis. Front Immunol (2013) 4:266. 10.3389/fimmu.2013.00266</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00266</ArticleId><ArticleId IdType="pmc">PMC3764426</ArticleId><ArticleId IdType="pubmed">24046769</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara LJ, Medina G, Saavedra MA. Autoimmune&#xa0;Manifestations&#xa0;Of&#xa0;Infections. Curr Opin Rheumatol (2018) 30(4):373&#x2013;9. 10.1097/BOR.0000000000000505</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000505</ArticleId><ArticleId IdType="pubmed">29528865</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;nnblom L. The&#xa0;Importance&#xa0;of The&#xa0;Type&#xa0;I&#xa0;Interferon&#xa0;System in Autoimmunity. Clin Exp Rheumatol (2016) 34(4 Suppl 98):21&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">27586799</ArticleId></ArticleIdList></Reference><Reference><Citation>Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses&#xa0;And&#xa0;Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms. Viruses (2019) 11(8):762. 10.3390/v11080762</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11080762</ArticleId><ArticleId IdType="pmc">PMC6723519</ArticleId><ArticleId IdType="pubmed">31430946</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacchi MC, Tamiazzo S, Stobbione P, Agatea L, De Gaspari P, Stecca A, et al. . Sars-CoV-2&#xa0;infection&#xa0;as A&#xa0;Trigger&#xa0;Of&#xa0;Autoimmune&#xa0;Response. Clin Transl Sci (2020). 10.1111/cts.12953</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12953</ArticleId><ArticleId IdType="pmc">PMC8212749</ArticleId><ArticleId IdType="pubmed">33306235</ArticleId></ArticleIdList></Reference><Reference><Citation>Caso F, Costa L, Ruscitti P, Navarini L, Del Puente A, Giacomelli R, et al. . Could Sars-coronavirus-2 Trigger Autoimmune and/or Autoinflammatory Mechanisms in Genetically Predisposed Subjects? Autoimmun Rev (2020) 19(5):102524. 10.1016/j.autrev.2020.102524</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102524</ArticleId><ArticleId IdType="pmc">PMC7271072</ArticleId><ArticleId IdType="pubmed">32220633</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafi S, Rajaei E, Moallemian R, Nokhostin F. The Potential Similarities of&#xa0;COVID-19&#xa0;and Autoimmune Disease Pathogenesis and Therapeutic Options: New Insights Approach. Clin Rheumatol (2020) 39(11):3223&#x2013;35. 10.1007/s10067-020-05376-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05376-x</ArticleId><ArticleId IdType="pmc">PMC7471540</ArticleId><ArticleId IdType="pubmed">32885345</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascolini S, Vannini A, Deleonardi G, Ciordinik M, Sensoli A, Carletti I, et al. . COVID-19 and Immunological Dysregulation: Can&#xa0;Autoantibodies&#xa0;Be&#xa0;Useful? Clin Transl Sci (2021) 14(2):502&#x2013;8. 10.1111/cts.12908</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12908</ArticleId><ArticleId IdType="pmc">PMC7536986</ArticleId><ArticleId IdType="pubmed">32989903</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonometti R, Sacchi MC, Stobbione P, Lauritano EC, Tamiazzo S, Marchegiani A, et al. . The First Case of Systemic Lupus Erythematosus (SLE) Triggered by COVID-19 Infection. Eur Rev Med Pharmacol Sci (2020) 24(18):9695&#x2013;7. 10.26355/eurrev_202009_23060</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202009_23060</ArticleId><ArticleId IdType="pubmed">33015814</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani Cardoso E, Hundal J, Feterman D, Magaldi J. Concomitant New Diagnosis of Systemic Lupus Erythematosus and COVID-19 With Possible Antiphospholipid Syndrome. Just a Coincidence? A Case Report and Review of Intertwining Pathophysiology. Clin Rheumatol (2020) 39(9):2811&#x2013;5. 10.1007/s10067-020-05310-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05310-1</ArticleId><ArticleId IdType="pmc">PMC7384868</ArticleId><ArticleId IdType="pubmed">32720260</ArticleId></ArticleIdList></Reference><Reference><Citation>Gracia-Ramos AE, Saavedra-Salinas M&#xc1;. Can the SARS-CoV-2 Infection Trigger Systemic Lupus Erythematosus? A Case-Based Review. Rheumatol Int (2021) 41(4):799&#x2013;809. 10.1007/s00296-021-04794-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04794-7</ArticleId><ArticleId IdType="pmc">PMC7861004</ArticleId><ArticleId IdType="pubmed">33543338</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedaghat Z, Karimi N. Guillain&#xa0;Barre&#xa0;Syndrome Associated With&#xa0;COVID-19&#xa0;infection: A&#xa0;Case&#xa0;Report. J Clin Neurosci (2020) 76:233&#x2013;5. 10.1016/j.jocn.2020.04.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.04.062</ArticleId><ArticleId IdType="pmc">PMC7158817</ArticleId><ArticleId IdType="pubmed">32312628</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalalzadeh M, Valencia-Manrique JC, Boma N, Chaudhari A, Chaudhari S. Antineutrophil&#xa0;Cytoplasmic&#xa0;Antibody-Associated Glomerulonephritis in a Case of Scleroderma After Recent Diagnosis With&#xa0;Covid-19. Cureus (2021) 13(1):e12485. 10.7759/cureus.12485</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.12485</ArticleId><ArticleId IdType="pmc">PMC7861062</ArticleId><ArticleId IdType="pubmed">33564500</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Papa N, Sambataro G, Minniti A, Maglione W, Pignataro F, Caminati A, et al. . Impact&#xa0;Of&#xa0;COVID-19&#xa0;Outbreak in an Italian Cohort of Patients With&#xa0;Systemic Sclerosis. Ther Adv Musculoskelet Dis (2020). 10.1177/1759720X20953356</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759720X20953356</ArticleId><ArticleId IdType="pmc">PMC7522815</ArticleId><ArticleId IdType="pubmed">33029203</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulze-Koops H, Krueger K, Vallbracht I, Hasseli R, Skapenko A. Increased&#xa0;Risk&#xa0;For&#xa0;Severe&#xa0;COVID-19&#xa0;in Patients With Inflammatory Rheumatic Diseases Treated With&#xa0;Rituximab. Ann Rheum Dis (2020). 10.1136/annrheumdis-2020-218075</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218075</ArticleId><ArticleId IdType="pubmed">32591357</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan EKL, Damoiseaux J, Carballo OG, Conrad K, de Melo Cruvinel W, Francescantonio PLC, et al. . Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns (ICAP) 2014-2015. Front Immunol (2015) 20(6):412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4542633</ArticleId><ArticleId IdType="pubmed">26347739</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sawalha AH, Lu Q. COVID-19&#xa0;And&#xa0;Autoimmune&#xa0;Diseases. Curr Opin Rheumatol (2021) 33(2):155&#x2013;62. 10.1097/BOR.0000000000000776</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000776</ArticleId><ArticleId IdType="pmc">PMC7880581</ArticleId><ArticleId IdType="pubmed">33332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Scala E, Pallotta S, Frezzolini A, Abeni D, Barbieri C, Sampogna F, et al. . Cytokine and Chemokine Levels in Systemic Sclerosis: Relationship With Cutaneous and Internal Organ Involvement. Clin Exp Immunol (2004) 138(3):540&#x2013;6. 10.1111/j.1365-2249.2004.02642.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2004.02642.x</ArticleId><ArticleId IdType="pmc">PMC1809238</ArticleId><ArticleId IdType="pubmed">15544634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims JT, Krishnan V, Chang CY, Engle SM, Casalini G, Rodgers GH, et al. . Characterization of the Cytokine Storm Reflects Hyperinflammatory Endotelial Dysfunction in COVID-19. J Allergy Clin Immunol (2021) 147(1):107&#x2013;11. 10.1016/j.jaci.2020.08.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.08.031</ArticleId><ArticleId IdType="pmc">PMC7488591</ArticleId><ArticleId IdType="pubmed">32920092</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochhegger B, Zanon M, Altmayer S, Mandelli NS, St&#xfc;ker G, Mohammed TL, et al. . Covid-19 Mimics on Chest CT: A Pictorial Review and Radiologic Guide. Br J Radiol (2021) 94(1118):20200703. 10.1259/bjr.20200703</Citation><ArticleIdList><ArticleId IdType="doi">10.1259/bjr.20200703</ArticleId><ArticleId IdType="pmc">PMC7934294</ArticleId><ArticleId IdType="pubmed">33296607</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez Y, Novelli L, Rojas M, De Santis M, Acosta-Ampudia Y, Monsalve DM, et al. . Autoinflammatory And&#xa0;Autoimmune&#xa0;Conditions at the Crossroad Of&#xa0;COVID-19. J Autoimmun (2020) 114:102506. &#xa0;10.1016/j.jaut.2020.102506</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102506</ArticleId><ArticleId IdType="pmc">PMC7296326</ArticleId><ArticleId IdType="pubmed">32563547</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzog EL, Mathur A, Tager AM, Feghali-Bostwick C, Schneider F, Varga J. Review: Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis: How Similar and Distinct? Arthritis Rheumatol (2014) 66:1967&#x2013;78. 10.1002/art.38702</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38702</ArticleId><ArticleId IdType="pmc">PMC4340472</ArticleId><ArticleId IdType="pubmed">24838199</ArticleId></ArticleIdList></Reference><Reference><Citation>Fucikova J, Palova-Jelinkova L, Bartunkova J, Spisek R. Induction Of Tolerance And&#xa0;Immunity&#xa0;By&#xa0;Dendritic&#xa0;Cells: Mechanisms and Clinical Applications. Front Immunol (2019) 10:239. 10.3389/fimmu.2019.02393</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02393</ArticleId><ArticleId IdType="pmc">PMC6830192</ArticleId><ArticleId IdType="pubmed">31736936</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal SK. The Genetics of Systemic Sclerosis. Discov Med (2010) 10(51):134&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3803145</ArticleId><ArticleId IdType="pubmed">20807474</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>